TEAD2 and intrahepatic cholangiocarcinoma: ICC assay further confirmed that extract treatment promoted YAP nuclear translocation and a significant increase in its expression levels (Figure 9C), subsequently driving an increase in TEAD2 (Figure 9D,E).